As of 2025-12-23, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (175.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -399.7%.
The range of the Relative Valuation is (158.73) - (181.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.7x | 17.4x |
| Forward P/E multiples | 15.3x - 17.5x | 16.6x |
| Fair Price | (158.73) - (181.08) | (175.91) |
| Upside | -370.4% - -408.5% | -399.7% |
| Date | P/E |